Arthur B. Page’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,995
| Closed | -$538K | – | 43 |
|
|
2023
Q2 | $538K | Sell |
3,995
-1,200
| -23% | -$176K | 0.51% | 37 |
|
|
2023
Q1 | $828K | Hold |
5,195
| – | – | 0.78% | 37 |
|
|
2022
Q4 | $840K | Hold |
5,195
| – | – | 0.82% | 36 |
|
|
2022
Q3 | $697K | Hold |
5,195
| – | – | 0.73% | 39 |
|
|
2022
Q2 | $796K | Hold |
5,195
| – | – | 0.76% | 37 |
|
|
2022
Q1 | $842K | Sell |
5,195
-210
| -4% | -$30.5K | 0.66% | 40 |
|
|
2021
Q4 | $731K | Hold |
5,405
| – | – | 0.5% | 45 |
|
|
2021
Q3 | $583K | Buy |
5,405
+40
| +0.7% | +$4.57K | 0.43% | 44 |
|
|
2021
Q2 | $604K | Sell |
5,365
-300
| -5% | -$33.8K | 0.43% | 46 |
|
|
2021
Q1 | $613K | Hold |
5,665
| – | – | 0.46% | 48 |
|
|
2020
Q4 | $607K | Hold |
5,665
| – | – | 0.46% | 47 |
|
|
2020
Q3 | $497K | Buy |
5,665
+100
| +2% | +$9.41K | 0.41% | 47 |
|
|
2020
Q2 | $547K | Hold |
5,565
| – | – | 0.48% | 44 |
|
|
2020
Q1 | $424K | Hold |
5,565
| – | – | 0.42% | 45 |
|
|
2019
Q4 | $493K | Sell |
5,565
-1,300
| -19% | -$108K | 0.4% | 46 |
|
|
2019
Q3 | $520K | Sell |
6,865
-150
| -2% | -$10.3K | 0.44% | 46 |
|
|
2019
Q2 | $511K | Hold |
7,015
| – | – | 0.42% | 47 |
|
|
2019
Q1 | $565K | Hold |
7,015
| – | – | 0.47% | 46 |
|
|
2018
Q4 | $647K | Sell |
7,015
-720
| -9% | -$63.3K | 0.63% | 44 |
|
|
2018
Q3 | $732K | Sell |
7,735
-60
| -0.8% | -$5.69K | 0.62% | 44 |
|
|
2018
Q2 | $722K | Sell |
7,795
-10
| -0.1% | -$977 | 0.66% | 42 |
|
|
2018
Q1 | $738K | Buy |
7,805
+615
| +9% | +$67.6K | 0.67% | 42 |
|
|
2017
Q4 | $695K | Sell |
7,190
-125
| -2% | -$11.8K | 0.61% | 43 |
|
|
2017
Q3 | $650K | Sell |
7,315
-110
| -1% | -$8.37K | 0.57% | 44 |
|
|
2017
Q2 | $539K | Sell |
7,425
-840
| -10% | -$56.5K | 0.47% | 47 |
|
|
2017
Q1 | $538K | Sell |
8,265
-3,205
| -28% | -$201K | 0.48% | 48 |
|
|
2016
Q4 | $718K | Sell |
11,470
-3,130
| -21% | -$191K | 0.69% | 41 |
|
|
2016
Q3 | $921K | Sell |
14,600
-3,102
| -18% | -$201K | 0.9% | 36 |
|
|
2016
Q2 | $1.09M | Buy |
17,702
+2
| +0% | +$122 | 1.1% | 32 |
|
|
2016
Q1 | $1.01M | Buy |
17,700
+400
| +2% | +$22.3K | 1.03% | 36 |
|
|
2015
Q4 | $1.02M | Sell |
17,300
-600
| -3% | -$34.6K | 1.05% | 35 |
|
|
2015
Q3 | $974K | Buy |
17,900
+50
| +0.3% | +$3.25K | 1.03% | 36 |
|
|
2015
Q2 | $1.2M | Buy |
17,850
+2,350
| +15% | +$153K | 1.12% | 38 |
|
|
2015
Q1 | $907K | Buy |
15,500
+6,150
| +66% | +$372K | 0.86% | 39 |
|
|
2014
Q4 | $612K | Buy |
9,350
+2,390
| +34% | +$151K | 0.58% | 47 |
|
|
2014
Q3 | $402K | Buy |
6,960
+1,020
| +17% | +$56.6K | 0.4% | 52 |
|
|
2014
Q2 | $335K | Buy |
+5,940
| New | +$312K | 0.31% | 63 |
|
Other funds holding ABBV
Arthur B. Page's ABBV Position: Q3 2023 in Review
Arthur B. Page sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 3,995 shares — an estimated $538K sold.
Arthur B. Page first reported a position in ABBV in Q2 2014 and held it in 37 quarters. The position peaked at $1.2M in Q2 2015. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- Arthur B. Page reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
- Arthur B. Page sold 3,995 AbbVie shares in Q3 2023, an estimated $538K.
- Arthur B. Page first reported a position in AbbVie in Q2 2014 and held it in 37 quarters.
- Arthur B. Page's AbbVie position peaked at $1.2M in Q2 2015.
- 3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on Arthur B. Page's 13F filing for Q3 2023, filed 14 Nov 2023.